CBIO

CRESCENT BIOPHARMA INC.

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

CRESCENT BIOPHARMA INC. (CBIO) is held as common stock by 2 tracked hedge-fund managers, with a combined reported value of ~$12.67M; the largest are Izzy Englander, Steven Cohen. This quarter: 1 added, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · LowThis quarter · Quiet

Common-stock holders2

Congress trades0

Price$14.76vs quarter-end-18.00%

Sectors0

This quarter's moves

New0

Added1

Trimmed / sold1

Top holder

Izzy Englander

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Steven CohenHold

Value $5.40M0.0% of portfolio300,0002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Steven Cohen	2026 Q2	$5.40M	300,000	0.0%	Hold

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.